Skip to content
Dorian Therapeutics logo

Dorian Therapeutics

Dorian Therapeutics is a YC Summer 2018 (S18) company. Based in San Carlos, CA, USA. Team of 8.

  • Anti-Aging
  • Biotech
  • Therapeutics

About Dorian Therapeutics

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Dorian Therapeutics develops therapeutics targeting the biology of cellular aging to treat age-related diseases and tissue decline. The company works on restoring the capacity of cells to resist the stressors that drive disease, replacing the conventional approach of treating symptoms after degeneration has occurred. Its focus is translating rejuvenation science into medicines for conditions rooted in aging.

From the Y Combinator listing

How Dorian Therapeutics describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

New therapeutics to rejuvenate tissue and treat age-related diseases

Facts

Industry
Healthcare / Healthcare -> Therapeutics
Location
San Carlos, CA, USA
Team size
8
Status
Acquired
Stage
Early

Founders (2)

  • Benedetta di Robilant
    Founder
  • Maddalena Adorno
    Founder

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works